ANXA5 and breast cancer: Breast cancer cells treated with CB showed cleaved PARP; increased levels of proapoptotic protein BIM; and increased annexin V staining compared with vehicle-treated cells, as revealed by FACS (Fig. 6e) and western blots analysis.